Abbott Laboratories ABT reported third-quarter 2024 adjusted earnings per share (EPS) of $1.21, which beat the Zacks ...

Abbott Laboratories (ABT) shares tick into positive territory in Wednesday's pre-market trading on its third quarter earnings ...

Chicago, IL – October 16, 2024 – Today, Zacks Investment Ideas feature highlights Abbott Laboratories ABT, Equifax EFX and SL ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results ...

Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and sales, boosted by strength in the ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

Abbott has raised the midpoint of its full-year income guidance as the group was bolstered by solid sales of medical devices ...

Abbott Laboratories (ABT) revealed earnings for its third quarter that increased from the same period last year and beat the Street ...

On a per-share basis, the Abbott Park, Illinois-based company said it had profit of 94 cents. Earnings, adjusted for non-recurring costs, came to $1.21 per share. The results topped Wall Street ...

Abbott's Q3 sales reached $10.64B, beating the consensus of $10.55B ... beating the analyst estimates of $1.20. Also Read: ...

Welcome to Abbott's third quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...